AstraZeneca employs nearly 12,000 people in R&D. We have six major joint discovery and development facilities in the UK, US and Sweden

We have a further four sites in the US, Canada, India and France which focus solely on discovery, and a facility in Japan dedicated to development. These resources are complemented by clinical development at 43 sites around the world.

R&D is a globally-managed organisation which is therapy area led and project driven. At the same time we form partnerships with academia, governments, regulators, healthcare providers and major industry collaborators.